Cite

HARVARD Citation

    Shah, A. et al. (2022). A multiparametric pharmacogenomic strategy for drug repositioning predicts therapeutic efficacy for glioblastoma cell lines. Neuro-oncology advances. 4 (1), p. . [Online]. 
  
Back to record